These two BCFAs are associated with obesity and insulin resistance in a murine model, directly promote hepatic glucose production, and activate mTORC1/S6K1 signaling in vitro[48]. Here, RPS6KB1 is linked to obesity due to melanocortin 4 receptor deficiency.